Brown, Lisle/Cummings’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Brown, Lisle/Cummings's PFE Position: Q3 2026 in Review
Brown, Lisle/Cummings reduced its Pfizer (PFE) stake by 4.6% in Q3 2026, selling an estimated $91.7K and leaving 71,290 shares worth $2.03M. The position accounts for 0.45% of the portfolio, ranked #53.
Brown, Lisle/Cummings first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Brown, Lisle/Cummings held 71,290 shares of Pfizer worth $2.03M as of Q3 2026.
- Brown, Lisle/Cummings sold 3,447 Pfizer shares in Q3 2026, an estimated $91.7K.
- Pfizer made up 0.45% of Brown, Lisle/Cummings's portfolio in Q3 2026, its #53 holding.
- Brown, Lisle/Cummings first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q3 2026, filed 16 Oct 2026.